Reactivating Immunity Primed by Acellular Pertussis Vaccines in the Absence of Circulating Antibodies: Enhanced Bacterial Control by TLR9 Rather Than TLR4 Agonist-Including Formulation

A Two-Dose Hepatitis B Vaccine for Adults (Heplisav-B)

(2018)   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Correlates of adjuvanticity: A review on adjuvants in licensed vaccines

(2018) Giuseppe Del Giudice et al.   SEMINARS IN IMMUNOLOGY

Whole-cell or acellular pertussis vaccination in infancy determines IgG subclass profiles to DTaP booster vaccination

(2018) Saskia van der Lee et al.   VACCINE

Th1/Th17 polarization persists following whole-cell pertussis vaccination despite repeated acellular boosters

(2018) Ricardo da Silva Antunes et al.   JOURNAL OF CLINICAL INVESTIGATION

Review of maternal immunisation during pregnancy: focus on pertussis and influenza

(2017)   SWISS MEDICAL WEEKLY

Addition of a TLR7 agonist to an acellular pertussis vaccine enhances Th1 and Th17 responses and protective immunity in a mouse model

(2017) Alicja Misiak et al.   VACCINE

What Is Wrong with Pertussis Vaccine Immunity?

(2017) Nicolas Burdin et al.   Cold Spring Harbor Perspectives in Biology

Th1 versus Th2 T cell polarization by whole-cell and acellular childhood pertussis vaccines persists upon re-immunization in adolescence and adulthood

(2016) Tara Bancroft et al.   CELLULAR IMMUNOLOGY

Immunoproteomic Profiling of Bordetella pertussis Outer Membrane Vesicle Vaccine Reveals Broad and Balanced Humoral Immunogenicity

(2015) René H. M. Raeven et al.   JOURNAL OF PROTEOME RESEARCH

Needle-free and adjuvant-free epicutaneous boosting of pertussis immunity: Preclinical proof of concept

(2015) Beatris Mastelic Gavillet et al.   VACCINE

Modulation of the CD4+ T cell response after acellular pertussis vaccination in the presence of TLR4 ligation

(2015) Jolanda Brummelman et al.   VACCINE

A Change in Vaccine Efficacy and Duration of Protection Explains Recent Rises in Pertussis Incidence in the United States

(2015) Manoj Gambhir et al.   PLoS Computational Biology

Roads to the development of improved pertussis vaccines paved by immunology

(2015) Jolanda Brummelman et al.   Pathogens and Disease

The baboon model of pertussis: effective use and lessons for pertussis vaccines

(2014) Jason M Warfel et al.   Expert Review of Vaccines

Lipopolysaccharides from Bordetella pertussis and Bordetella parapertussis Differently Modulate Human Dendritic Cell Functions Resulting in Divergent Prevalence of Th17-Polarized Responses

(2014) G. Fedele et al.   JOURNAL OF IMMUNOLOGY

Mouse and Pig Models for Studies of Natural and Vaccine-Induced Immunity to Bordetella pertussis

(2014) K. H. G. Mills et al.   JOURNAL OF INFECTIOUS DISEASES

Pertussis Vaccine Trials in the 1990s

(2014) L. C. Lambert   JOURNAL OF INFECTIOUS DISEASES

A novel TLR2 agonist from Bordetella pertussis is a potent adjuvant that promotes protective immunity with an acellular pertussis vaccine

(2014) A Dunne et al.   Mucosal Immunology

A Comparative Review of Toll-Like Receptor 4 Expression and Functionality in Different Animal Species

(2014) Céline Vaure et al.   Frontiers in Immunology

Complex Correlates of Protection After Vaccination

(2013) S. A. Plotkin   CLINICAL INFECTIOUS DISEASES

Reduced Risk of Pertussis Among Persons Ever Vaccinated With Whole Cell Pertussis Vaccine Compared to Recipients of Acellular Pertussis Vaccines in a Large US Cohort

(2013) Maxwell A. Witt et al.   CLINICAL INFECTIOUS DISEASES

Comparative Effectiveness of Acellular Versus Whole-Cell Pertussis Vaccines in Teenagers

(2013) N. P. Klein et al.   PEDIATRICS

Acellular pertussis vaccines protect against disease but fail to prevent infection and transmission in a nonhuman primate model

(2013) J. M. Warfel et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

A CpG-containing oligodeoxynucleotide adjuvant for acellular pertussis vaccine improves the protective response againstBordetella pertussis

(2013) Catpagavalli Asokanathan et al.   Human Vaccines & Immunotherapeutics

Relative Contribution of Th1 and Th17 Cells in Adaptive Immunity to Bordetella pertussis: Towards the Rational Design of an Improved Acellular Pertussis Vaccine

(2013) Pádraig J. Ross et al.   PLoS Pathogens

Unexpectedly Limited Durability of Immunity Following Acellular Pertussis Vaccination in Preadolescents in a North American Outbreak

(2012) S. L. Sheridan et al.   CLINICAL INFECTIOUS DISEASES

Genotypic and phenotypic characterization of Bordetella pertussis strains used in different vaccine formulations in Latin America

(2012) D. Bottero et al.   JOURNAL OF APPLIED MICROBIOLOGY

Waning Protection after Fifth Dose of Acellular Pertussis Vaccine in Children

(2012) Nicola P. Klein et al.   NEW ENGLAND JOURNAL OF MEDICINE

Antibodies Recognizing Protective Pertussis Toxin Epitopes Are Preferentially Elicited by Natural Infection versus Acellular Immunization

(2011) Jamie N. Sutherland et al.   Clinical and Vaccine Immunology

Different IgG-subclass distributions after whole-cell and acellular pertussis infant primary vaccinations in healthy and pertussis infected children

(2011) Lotte H. Hendrikx et al.   VACCINE

Pertussis Toxin Up-regulates Angiotensin Type 1 Receptors through Toll-like Receptor 4-mediated Rac Activation

(2010) Motohiro Nishida et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Differential Effect of TLR2 and TLR4 on the Immune Response after Immunization with a Vaccine against Neisseria meningitidis or Bordetella pertussis

(2010) Floris Fransen et al.   PLoS One

IgG responses after booster vaccination with different pertussis vaccines in Dutch children 4 years of age: Effect of vaccine antigen content

(2009) Lotte H. Hendrikx et al.   VACCINE

The role of Toll-like receptor-4 in pertussis vaccine-induced immunity

(2008) Sander Banus et al.   BMC IMMUNOLOGY